Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages
- PMID: 16876282
- DOI: 10.1016/j.jconrel.2006.04.010
Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages
Abstract
Carbohydrate grafted emulsions are one of the most promising cell-specific targeting systems for lipophilic drugs. We have previously reported that mannosylated (Man-) emulsions composed of soybean oil, EggPC and cholesten-5-yloxy-N-(4-((1-imino-2-d-thiomannosylethyl)amino)alkyl)formamide (Man-C4-Chol) with a ratio of 70:25:5 were significantly delivered to liver non-parenchymal cells (NPC) via mannose receptor-mediated mechanism after intravenous administration in mice. Since the efficient targeting through a receptor-mediated mechanism is largely controlled by ligand-receptor interaction, the effect of mannose density on Man-emulsions was studied with regard to both the disposition in vivo in mice and the uptake in vitro, using elicited macrophages which express a number of mannose receptors. After intravenous injection, Man-emulsions with 5.0% (Man-5.0-emulsions) and 7.5% (Man-7.5-emulsions) of Man-C4-Chol were rapidly eliminated from the blood circulation and preferentially accumulated in the liver-NPC compared with Man-emulsions with 2.5% of Man-C4-Chol (Man-2.5-emulsions) and bare emulsions (Bare-emulsions). The in vitro study showed increased internalization of Man-5.0- and Man-7.5-emulsions and significant inhibition of uptake in the presence of mannan. The enhanced uptake of Man-emulsions was related to the increasing of Man-C4-Chol content that corresponded to confocal microscopy study. These results suggest that the mannose density of Man-emulsions plays an important role in both cellular recognition and internalization via a mannose receptor-mediated mechanism.
Similar articles
-
Biodistribution characteristics of mannosylated and fucosylated O/W emulsions in mice.J Drug Target. 2005 Sep-Nov;13(8-9):479-87. doi: 10.1080/10611860500293367. J Drug Target. 2005. PMID: 16332573
-
Involvement of serum mannan binding proteins and mannose receptors in uptake of mannosylated liposomes by macrophages.Biochim Biophys Acta. 2001 Mar 9;1511(1):134-45. doi: 10.1016/s0005-2736(01)00267-x. Biochim Biophys Acta. 2001. PMID: 11248212
-
Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats.J Control Release. 2008 Jan 22;125(2):121-30. doi: 10.1016/j.jconrel.2007.10.011. Epub 2007 Oct 22. J Control Release. 2008. PMID: 18037185
-
Mannosylated Constructs as a Platform for Cell-Specific Delivery of Bioactive Agents.Crit Rev Ther Drug Carrier Syst. 2018;35(2):157-194. doi: 10.1615/CritRevTherDrugCarrierSyst.2018020313. Crit Rev Ther Drug Carrier Syst. 2018. PMID: 29717665 Review.
-
Mannose-targeted systems for the delivery of therapeutics.Expert Opin Drug Deliv. 2008 Jun;5(6):703-24. doi: 10.1517/17425247.5.6.703. Expert Opin Drug Deliv. 2008. PMID: 18532925 Review.
Cited by
-
A Novel Bivalent Mannosylated Targeting Ligand Displayed on Nanoparticles Selectively Targets Anti-Inflammatory M2 Macrophages.Pharmaceutics. 2020 Mar 8;12(3):243. doi: 10.3390/pharmaceutics12030243. Pharmaceutics. 2020. PMID: 32182675 Free PMC article.
-
Development of mannosylated liposomes using synthesized N-octadecyl-D-mannopyranosylamine to enhance gastrointestinal permeability for protein delivery.AAPS PharmSciTech. 2012 Jun;13(2):699-706. doi: 10.1208/s12249-012-9788-1. Epub 2012 May 5. AAPS PharmSciTech. 2012. PMID: 22562613 Free PMC article.
-
Noncovalent Targeting of Nanocarriers to Immune Cells with Polyphosphoester-Based Surfactants in Human Blood Plasma.Adv Sci (Weinh). 2019 Oct 4;6(22):1901199. doi: 10.1002/advs.201901199. eCollection 2019 Nov. Adv Sci (Weinh). 2019. PMID: 31763142 Free PMC article.
-
Fucosylated multiwalled carbon nanotubes for Kupffer cells targeting for the treatment of cytokine-induced liver damage.Pharm Res. 2014 Feb;31(2):322-34. doi: 10.1007/s11095-013-1162-9. Epub 2013 Sep 17. Pharm Res. 2014. PMID: 24043294
-
Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.Pharm Res. 2011 Jul;28(7):1500-19. doi: 10.1007/s11095-010-0339-8. Epub 2010 Dec 23. Pharm Res. 2011. PMID: 21181549 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous